Axa S.A (CS) | Financial Analysis & Statements
Axa S.A. | Large-cap | Financial Services
Axa S.A. | Large-cap | Financial Services
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
89.8B
Net Income
8.1B
8.99%
EPS (Diluted)
€3.30
Balance Sheet Metrics
Total Assets
653.8B
Total Liabilities
601.3B
Shareholders Equity
52.5B
Debt to Equity
11.46
Cash Flow Metrics
Operating Cash Flow
24.8B
Free Cash Flow
12.0B
Revenue & Profitability Trend
Axa S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 89.8B | 84.6B | 69.1B | 111.7B | 102.9B |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 2.8B | 3.0B | 14.2B | 10.9B | 10.6B |
| Operating Income | - | - | - | - | - |
| Pre-tax Income | 10.0B | 8.4B | 6.6B | 9.2B | 4.9B |
| Income Tax | 2.5B | 1.4B | 1.4B | 1.7B | 1.5B |
| Net Income | 8.1B | 7.4B | 5.2B | 7.5B | 3.3B |
| EPS (Diluted) | €3.30 | €3.13 | €2.12 | €2.97 | €1.25 |
Income Statement Trend
Axa S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | - | - | - | - | - |
| Non-Current Assets | - | - | - | - | - |
| Total Assets | 653.8B | 644.4B | 638.4B | - | - |
| Liabilities | |||||
| Current Liabilities | - | - | - | - | - |
| Non-Current Liabilities | - | - | - | - | - |
| Total Liabilities | 601.3B | 592.0B | 589.3B | - | - |
| Equity | |||||
| Total Shareholders Equity | 52.5B | 52.4B | 49.1B | 55.6B | 76.2B |
Balance Sheet Composition
Axa S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 10.0B | 8.4B | 6.6B | 9.2B | 4.9B |
| Operating Cash Flow | 24.8B | 9.9B | 17.1B | 19.2B | 25.9B |
| Investing Activities | |||||
| Capital Expenditures | -459.0M | -398.0M | -365.0M | -344.0M | -386.0M |
| Investing Cash Flow | -7.4B | 2.4B | 9.5B | 502.0M | -6.9B |
| Financing Activities | |||||
| Dividends Paid | -4.5B | -3.9B | -3.7B | -3.5B | -1.7B |
| Financing Cash Flow | -6.4B | -3.5B | -5.5B | -3.6B | -3.8B |
| Free Cash Flow | 12.0B | 3.5B | 8.3B | 6.2B | 25.1B |
Cash Flow Trend
Axa S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.84
Forward P/E
10.92
Price to Book
1.82
Price to Sales
1.00
PEG Ratio
10.92
Profitability Ratios
Profit Margin
8.64%
Operating Margin
15.82%
Return on Equity
12.47%
Return on Assets
1.01%
Financial Health
Current Ratio
1.93
Debt to Equity
102.50
Beta
1.09
Per Share Data
EPS (TTM)
€3.25
Book Value per Share
€22.96
Revenue per Share
€41.65
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| cs | 90.8B | 12.84 | 1.82 | 12.47% | 8.64% | 102.50 |
| Argan REIT | 1.6B | 6.41 | 0.73 | 11.92% | 102.81% | 83.07 |
| L'Oréal S.A | 191.5B | 30.09 | 5.79 | 20.63% | 14.74% | 25.64 |
| Bolloré SE | 14.6B | 104.60 | 0.58 | 0.51% | 58.22% | 1.64 |
| Arkema S.A | 4.5B | 15.50 | 0.67 | 4.20% | 3.38% | 50.65 |
| Vallourec S.A | 3.5B | 8.31 | 1.37 | 18.18% | 10.73% | 38.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.